Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP705008.RAaNa88pgSMRrJZ3PVawWdXB-hEmfod9PGfX6k1GUGSD0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP705008.RAaNa88pgSMRrJZ3PVawWdXB-hEmfod9PGfX6k1GUGSD0130_assertion type Assertion NP705008.RAaNa88pgSMRrJZ3PVawWdXB-hEmfod9PGfX6k1GUGSD0130_head.
- NP705008.RAaNa88pgSMRrJZ3PVawWdXB-hEmfod9PGfX6k1GUGSD0130_assertion description "[The CDX2 polymorphism (GG versus AG/AA) was significantly associated with prostate cancer only in HW men with the V89L VV genotype (CDX2 OR, 3.16; 95% CI, 1.39-7.19; interaction term P = 0.02).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP705008.RAaNa88pgSMRrJZ3PVawWdXB-hEmfod9PGfX6k1GUGSD0130_provenance.
- NP705008.RAaNa88pgSMRrJZ3PVawWdXB-hEmfod9PGfX6k1GUGSD0130_assertion evidence source_evidence_literature NP705008.RAaNa88pgSMRrJZ3PVawWdXB-hEmfod9PGfX6k1GUGSD0130_provenance.
- NP705008.RAaNa88pgSMRrJZ3PVawWdXB-hEmfod9PGfX6k1GUGSD0130_assertion SIO_000772 18483391 NP705008.RAaNa88pgSMRrJZ3PVawWdXB-hEmfod9PGfX6k1GUGSD0130_provenance.
- NP705008.RAaNa88pgSMRrJZ3PVawWdXB-hEmfod9PGfX6k1GUGSD0130_assertion wasDerivedFrom befree-20140225 NP705008.RAaNa88pgSMRrJZ3PVawWdXB-hEmfod9PGfX6k1GUGSD0130_provenance.
- NP705008.RAaNa88pgSMRrJZ3PVawWdXB-hEmfod9PGfX6k1GUGSD0130_assertion wasGeneratedBy ECO_0000203 NP705008.RAaNa88pgSMRrJZ3PVawWdXB-hEmfod9PGfX6k1GUGSD0130_provenance.